Primary AML samples with Ara-C, Dnr or ATO IC50 above the median had significantly higher NRF2 RNA expression (p = 0.07, 0.004 and 0.01 respectively) compared to those below median (Fig 1A). The gene discussed is NFE2L2; the disease is acute myeloid leukemia.